Insulin release from human fetal pancreas in vitro.
D001120:Arginine / Q000494:pharmacology; D001464:Barium / Q000494:pharmacology; D001835:Body Weight; D000242:Cyclic AMP / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000378:metabolism; D005865:Gestational Age; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007930:Leucine / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000196:embryology* / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011247:Pregnancy; D013806:Theophylline / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology
D007328:Insulin; D001464:Barium; D010042:Ouabain; D005934:Glucagon; D001120:Arginine; D014044:Tolbutamide; D013806:Theophylline; D000242:Cyclic AMP; D007930:Leucine; D005947:Glucose; D011188:Potassium